Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiichirou Morimura

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2010
[Selection of anticancer drug for poorly-differentiated adenocarcinoma of colorectum from the level of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase activities in cancer tissue]Masashi Takemura, Keiichirou Morimura, Kayo Yoshida, et al.
Carcinogenesis|June 25, 2005
Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogensShoji Fukushima, Anna Kinoshita, Rawiwan Puatanachokchai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2010
[Correlation between clinicopathological factors and enzymatic activity of orotate phosphoribosyl transferase (OPRT), dihydropyrimidine dehydrogenase (DPD) in esophageal cancer]Masashi Takemura, Kayo Yoshida, Keiichirou Morimura, et al.
Mutagenesis|April 25, 2002
Effect of ethanol treatment on metabolic activation and detoxification of esophagus carcinogenic N-nitrosamines in rat liverYukio Mori, Akihiro Koide, Yoshinori Kobayashi, et al.
Cancer Science|December 22, 2005
Aberrant expression of E-cadherin and beta-catenin in association with transforming growth factor-beta1 in urinary bladder lesions in humans after the Chernobyl accidentAlina Romanenko, Keiichirou Morimura, Anna Kinoshita, et al.
Cancer Science|June 1, 2006
Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide-induced liver damage in ratsJin Seok Kang, Hideki Wanibuchi, Keiichirou Morimura, et al.
Oncology Reports|March 8, 2007
Analysis of gene expression in different stages of MeIQx-induced rat hepatocarcinogenesisJin Seok Kang, Hideki Wanibuchi, Takashi Murai, et al.
Toxicologic Pathology|December 1, 2005
Lack of urinary bladder carcinogenicity of sodium L-ascorbate in human c-Ha-ras proto-oncogene transgenic ratsKeiichirou Morimura, Jin Seok Kang, Min Wei, et al.
Carcinogenesis|December 27, 2005
Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesisKeiichirou Morimura, Connie Cheung, Jerrold M Ward, et al.
Plos One|November 25, 2014
Valerian inhibits rat hepatocarcinogenesis by activating GABA(A) receptor-mediated signalingAnna Kakehashi, Ayumi Kato, Naomi Ishii, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2010
[Selection of anticancer drug for poorly-differentiated adenocarcinoma of colorectum from the level of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase activities in cancer tissue]Masashi Takemura, Keiichirou Morimura, Kayo Yoshida, et al.
Carcinogenesis|June 25, 2005
Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogensShoji Fukushima, Anna Kinoshita, Rawiwan Puatanachokchai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2010
[Correlation between clinicopathological factors and enzymatic activity of orotate phosphoribosyl transferase (OPRT), dihydropyrimidine dehydrogenase (DPD) in esophageal cancer]Masashi Takemura, Kayo Yoshida, Keiichirou Morimura, et al.
Mutagenesis|April 25, 2002
Effect of ethanol treatment on metabolic activation and detoxification of esophagus carcinogenic N-nitrosamines in rat liverYukio Mori, Akihiro Koide, Yoshinori Kobayashi, et al.
Cancer Science|December 22, 2005
Aberrant expression of E-cadherin and beta-catenin in association with transforming growth factor-beta1 in urinary bladder lesions in humans after the Chernobyl accidentAlina Romanenko, Keiichirou Morimura, Anna Kinoshita, et al.
Cancer Science|June 1, 2006
Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide-induced liver damage in ratsJin Seok Kang, Hideki Wanibuchi, Keiichirou Morimura, et al.
Oncology Reports|March 8, 2007
Analysis of gene expression in different stages of MeIQx-induced rat hepatocarcinogenesisJin Seok Kang, Hideki Wanibuchi, Takashi Murai, et al.
Toxicologic Pathology|December 1, 2005
Lack of urinary bladder carcinogenicity of sodium L-ascorbate in human c-Ha-ras proto-oncogene transgenic ratsKeiichirou Morimura, Jin Seok Kang, Min Wei, et al.
Carcinogenesis|December 27, 2005
Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesisKeiichirou Morimura, Connie Cheung, Jerrold M Ward, et al.
Plos One|November 25, 2014
Valerian inhibits rat hepatocarcinogenesis by activating GABA(A) receptor-mediated signalingAnna Kakehashi, Ayumi Kato, Naomi Ishii, et al.
Pageof 9